Tedor Pharma, Inc. is announcing the appointment of Roger D. Martin as Chief Operating Officer. Tedor Pharma is pleased to have found a tremendously experienced individual in Roger Martin to assume an executive leadership role as we accelerate our growth and capabilities. Roger will round out the executive leadership team as Chief Operating Officer.
Carl E. Wooten, President & CEO, welcomes Roger and looks forward to his trusted and experienced insights as we continue through a very successful 2016 and beyond. “Roger’s depth of experience in the dynamic CMO/CDMO space is exceptional and his client centered approach will be invaluable as we rapidly scale our operations.” says Wooten.
In order to execute on hyper growth, Roger will be leveraging his extensive management, leadership, business development, contract negotiation, business-to-business service contracting, licensing, and pharmaceutical/contracted service marketing skills.